These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 32575012

  • 1. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.
    Marrero-Rosado BM, de Araujo Furtado M, Kundrick ER, Walker KA, Stone MF, Schultz CR, Nguyen DA, Lumley LA.
    Epilepsy Behav; 2020 Oct; 111():107229. PubMed ID: 32575012
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
    Nguyen DA, Stone MF, Schultz CR, de Araujo Furtado M, Niquet J, Wasterlain CG, Lumley LA.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):376-385. PubMed ID: 37770198
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J, Lumley L, Baldwin R, Rossetti F, Schultz M, de Araujo Furtado M, Suchomelova L, Naylor D, Franco-Estrada I, Wasterlain CG.
    Epilepsy Behav; 2019 Dec 17; 101(Pt B):106367. PubMed ID: 31636007
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Delayed midazolam dose effects against soman in male and female plasma carboxylesterase knockout mice.
    Kundrick E, Marrero-Rosado B, Stone M, Schultz C, Walker K, Lee-Stubbs RB, de Araujo Furtado M, Lumley LA.
    Ann N Y Acad Sci; 2020 Nov 17; 1479(1):94-107. PubMed ID: 32027397
    [Abstract] [Full Text] [Related]

  • 7. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.
    Lumley LA, Marrero-Rosado B, Rossetti F, Schultz CR, Stone MF, Niquet J, Wasterlain CG.
    Epilepsia Open; 2021 Dec 17; 6(4):757-769. PubMed ID: 34657398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J, Nguyen D, de Araujo Furtado M, Lumley L.
    Epilepsia Open; 2023 May 17; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cannabidiol reduces soman-induced lethality and seizure severity in female plasma carboxylesterase knockout mice treated with midazolam.
    Kundrick ER, Marrero-Rosado BM, de Araujo Furtado M, Stone M, Schultz CR, Lumley LA.
    Neurotoxicology; 2021 Jan 17; 82():130-136. PubMed ID: 33290784
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors.
    Lumley L, Niquet J, Marrero-Rosado B, Schultz M, Rossetti F, de Araujo Furtado M, Wasterlain C.
    Neuropharmacology; 2021 Mar 01; 185():108444. PubMed ID: 33359073
    [Abstract] [Full Text] [Related]

  • 14. Novel Genetically Modified Mouse Model to Assess Soman-Induced Toxicity and Medical Countermeasure Efficacy: Human Acetylcholinesterase Knock-in Serum Carboxylesterase Knockout Mice.
    Marrero-Rosado BM, Stone MF, de Araujo Furtado M, Schultz CR, Cadieux CL, Lumley LA.
    Int J Mol Sci; 2021 Feb 14; 22(4):. PubMed ID: 33672922
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel genetically modified mouse seizure model for evaluating anticonvulsive and neuroprotective efficacy of an A1 adenosine receptor agonist following soman intoxication.
    Shih TM.
    Toxicol Appl Pharmacol; 2023 Apr 01; 464():116437. PubMed ID: 36849019
    [Abstract] [Full Text] [Related]

  • 17. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.
    Jackson C, Ardinger C, Winter KM, McDonough JH, McCarren HS.
    J Pharmacol Toxicol Methods; 2019 Apr 01; 97():1-12. PubMed ID: 30790623
    [Abstract] [Full Text] [Related]

  • 18. Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats.
    Lumley LA, Rossetti F, de Araujo Furtado M, Marrero-Rosado B, Schultz CR, Schultz MK, Niquet J, Wasterlain CG.
    Data Brief; 2019 Dec 01; 27():104629. PubMed ID: 31687442
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
    De Araujo Furtado M, Aroniadou-Anderjaska V, Figueiredo TH, Pidoplichko VI, Apland JP, Rossetti K, Braga MFM.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):432-450. PubMed ID: 37739807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.